Market Tracker

10/22 6:06pm ET

Trovagene Inc (NASDAQ:TROV)

4.24
Data as of 3:58pm ET
 -0.21 / -4.72%
Today’s Change
2.97
Today|||52-Week Range
7.91
-26.13%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close4.45
Today’s open4.40
Day’s range4.20 - 4.40
Volume31,805
Average volume (3 months)167,966
Market cap$84.1M
Dividend yield--
Data as of 3:58pm ET, 10/22/2014

Growth & Valuation

Earnings growth (last year)+21.35%
Earnings growth (this year)-22.86%
Earnings growth (next 5 years)--
Revenue growth (last year)-42.44%
P/E ratioNM
Price/Sales375.92
Price/Book4.13

Competitors

 Today’s
change
Today’s
% change
LPDXLipoScience Inc+0.01+0.19%
CGIXCancer Genetics Inc+0.16+2.04%
GALTGalectin Therapeutic...-0.33-6.48%
PANGPanacea Global Inc0.000.00%
Data as of 3:59pm ET, 10/22/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$259.2K
Annual profit (last year)-$11.8M
Net profit margin-4,555.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts